More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Press Releases
    • Media Coverage
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Press Releases
    • Media Coverage

MJNA Reaches Global Settlement of Pending Litigation with CannaVest

by Jeffrey Stamberger | Jul 22, 2015 | Cannabis Beauty Defined, Company News, Press Releases

MJNA CEO Lauds IP ‘Windfall’ in Brands Secured in Settlement, Along With ‘Significant Expense Removed’ SAN DIEGO, July 22, 2015 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA), a leading industrial hemp industry innovator, is...
Next Entries »

POPULAR

  • Medical Marijuana, Inc. Subsidiaries Kannaway®, HempMeds® and Dixie Botanicals Receive U.S. Hemp Authority Certification Seal
  • Medical Marijuana Inc. Gives Update on Dixie Botanicals Dixie Botanicals
  • Medical Marijuana, Inc. Launches Dixie Botanicals Canada®
  • Benzinga, The Motley Fool, and Wharton Business Radio Include Coverage of Medical Marijuana, Inc.
  • PhytoSPHERE Systems, a Medical Marijuana Inc Portfolio Company, to Bring Production Facilities to Europe through Canipa Holdings CanChew Dixie Botanicals phytosphere systems Red Dice Holdings

LAST NEWS

  • Medical Marijuana, Inc.’s Subsidiary HempMeds® Mexico to Sponsor and Exhibit at Expoweed Conference in Mexico City
  • Medical Marijuana, Inc. Subsidiary Kannaway® Recognizes First-Ever Brand Ambassadors to Achieve Crown Ambassador Elite Rank
  • Medical Marijuana, Inc. Major Investment Company Axim® Biotechnologies Files New U.S. Provisional Patent for Cannabis Gum as a Treatment for Migraine Symptoms
  • Medical Marijuana, Inc. Subsidiary Kannaway® Announces New Seasonal Peppermint Chocolate Energy Chews
  • Medical Marijuana, Inc. Subsidiary Kannaway® Enters CBN Market; Expands Cannabinoid Portfolio

SUBSCRIBE AND GET THE LATES NEWS

* indicates required

Follow us on

social networks

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.